The 2026 Healthtech Messaging Index
MedRhythms
medrhythms.com·scored August 23, 2026
21/38
Invisible
The page is doing some work, but the story isn't landing fast enough. Buyers and AI are both left guessing what makes MedRhythms different.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for Prescription digital therapeutics for neurological gait rehabilitation, it named:
Buyer we put in the prompt: Neurologist, physiatrist, or rehabilitation clinician at a hospital or outpatient rehab clinic looking to prescribe digital therapeutic devices for patients with stroke or Parkinson's disease walking impairments. Both the buyer and the category were inferred from MedRhythms’s homepage alone. The model had no web access.
MedRhythms was on the list.
AI named them for their own category. That's the signal every homepage is supposed to send.
AI named you when asked who it recommends for "Prescription digital therapeutics for neurological gait rehabilitation", and described you accurately: "MedRhythms is a digital therapeutics company that uses rhythmic auditory stimulation ... music synchronized to a patient's gait ... to rehabilitate walking in neurological conditions like stroke and Parkinson's disease.". Your positioning is landing with the machines.
Overall assessment
MedRhythms' biggest strength is its entity distinctiveness: owned terminology (RAS, InTandem, MOVIVE), a genuinely scarce founder credential, and the world's first prescription music platform framing make it unmistakable to AI and informed buyers. The biggest gap is the complete absence of buyer-facing proof ... no named prescriber testimonials, no patient outcome deltas, no before/after data ... which means credibility rests on inputs (hours, studies) rather than demonstrated results, and no competitive alternatives are ever acknowledged, leaving a serious trust vacuum for any buyer doing due diligence.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
02Rebellion / Movement
“No named enemy, no named status quo, no industry pattern called out anywhere on the page.”
The page is entirely missionary in tone about its own mission but never names what it is pushing against ... traditional PT, pharma, or doing nothing ... so there is no rebellion or movement framing.
All 19 signals, scored 0 to 2.
Total 21/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“Next-generation neurotherapeutics / Leveraging the power of music and technology to redefine what's possible in brain health”
The problem space (brain health/walking) and medium (music+tech) are inferable, but 'neurotherapeutics' is jargon and the hero fails the caveman test ... a stranger won't instantly know who this is for or what the product literally does.
- 0
02Rebellion / Movementweakest
“No named enemy, no named status quo, no industry pattern called out anywhere on the page.”
The page is entirely missionary in tone about its own mission but never names what it is pushing against ... traditional PT, pharma, or doing nothing ... so there is no rebellion or movement framing.
- 2
03Owned Language & Category
“rhythmic auditory stimulation (RAS)" and "World's first prescription music platform”
MedRhythms owns the term 'RAS' with a linked citation, coins 'prescription music platform,' and names its products InTandem and MOVIVE ... giving AI distinct, quotable, ownable language.
- 1
04ICP Clarity
“ambulatory adults with stroke walking impairments" and "people with Parkinson's disease (PD)”
The patient condition is named specifically, but the actual B2B buyer ... neurologist, rehab hospital, prescribing clinician ... is never addressed directly, leaving the ICP partially visible at best.
- 1
05Problem Leadership
“Millions of people live with persistent walking deficits... Walking disability significantly decreases independence, reduces quality of life, increases falls”
The page does lead with patient pain but frames it in clinical/mission language rather than the prescribing buyer's problem language, so it leads with a problem but not the right protagonist's problem.
- 1
06Solution Clarity
“digital therapeutics... via a proprietary, patented technology platform... combines sensors, software, and music with advanced neuroscience”
A visitor can piece together roughly what the company does, but the hero copy ('next-generation neurotherapeutics') is too abstract ... someone can't repeat a clean one-sentence explanation after reading only the above-fold section.
- 1
07Cost of Inaction
“Walking disability significantly decreases independence, reduces quality of life, increases falls, and adds to healthcare system burden”
Stakes are listed for patients but there is no explicit cost-of-inaction framing for the prescribing buyer or payer ... no named penalty for not adopting this therapy.
- 1
08Promised Land
“rewrite this story by developing transformative and innovative therapeutics" and "See if you qualify”
The promised 'after' state is implied (improved walking, more independence) but never painted concretely with specifics like gait speed improvements or patient quality-of-life metrics.
Trust Signal
4 signals
- 1
09Proof & Evidence
“over 50 clinical research studies" and "75,000 hours of clinical experience" and "over 30,000 hours of direct patient care”
There are concrete numbers but they are input metrics (hours, studies) with no before/after outcome deltas or patient result statistics that demonstrate actual efficacy in plain terms.
- 1
10Social Proof
“Media logos: "techcrunch," "forbes" visible; no customer names, testimonials with titles, or named patient/clinic case studies.”
Press logo bar provides light credibility but there are zero named customer testimonials, clinic case studies, or prescriber quotes ... social proof is thin and anonymous.
- 2
11Authority & Credibility
“Brian Harris, is a board-certified Neurologic Music Therapist and one of only 350 professionals globally with advanced training”
Founder credentials are specific, scarce, and verifiable ... 350 globally is a powerful scarcity claim ... and the Spaulding Rehabilitation Hospital origin story and Universal Music Group collaboration add layered authority.
- 0
12Alternatives Acknowledged
“No mention of alternative treatments, physical therapy, competing DTx products, or 'do nothing' option anywhere on the page.”
The page never acknowledges that buyers have other choices (traditional PT, competing DTx, medication), missing a key trust-building opportunity entirely.
AI Signal
6 signals
- 1
13Customer Focus
“We exist to positively impact the lives of those living with these deficits" vs. patient-as-protagonist framing throughout.”
The page toggles between company mission language ('we exist,' 'we are developing') and patient empathy, tilting toward the company as protagonist rather than making the patient or prescriber the clear hero.
- 2
14AI-Parmesan Index
“No AI-powered claims anywhere on the page; technology described mechanistically: "sensors, software, and music with advanced neuroscience to target neural circuitry.”
MedRhythms does not sprinkle AI marketing language ... its tech claims are grounded in neuroscience mechanisms and cited research, earning a clean score under this criterion.
- 1
15LLM Quotability
“World's first prescription music platform" and "one of only 350 professionals globally with advanced training in the clinical application of neuroscience and music”
A couple of sentences are quotable and distinctive, but most of the page is too diffuse and mission-heavy to produce the clean, declarative LLM-ready soundbites needed for confident AI citation.
- 0
16Copyright Freshness
“Copyright year not visible in scraped content; blog/case study dates absent; image URL shows '2026/05' which is anomalous and not a trust signal.”
No visible recent publication dates on blog posts or case studies appear in the page content, and no copyright year is present ... AI recency signals are effectively absent.
- 2
17Entity Distinctiveness
“rhythmic auditory stimulation (RAS)" + "World's first prescription music platform" + Universal Music Group + Brian Harris '350 globally' + InTandem + MOVIVE”
The combination of owned terminology, specific founder scarcity, named UMG partnership, and two branded FDA-cleared products makes this company unmistakably distinct ... an AI could not attribute this profile to a competitor.
- 2
18AI Recommendation Check
“AI described you as: "MedRhythms is a digital therapeutics company that uses rhythmic auditory stimulation ... music synchronized to a patient's gait ... to rehabilitate walking in neurological conditions like stroke and Parkinson's disease.”
AI named you when asked who it recommends for "Prescription digital therapeutics for neurological gait rehabilitation", and described you accurately: "MedRhythms is a digital therapeutics company that uses rhythmic auditory stimulation ... music synchronized to a patient's gait ... to rehabilitate walking in neurological conditions like stroke and Parkinson's disease.". Your positioning is landing with the machines.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“See if you qualify" CTA in hero; "Learn More" secondary; no numbered steps or clear process shown on page.”
There is a primary CTA and a soft secondary but no visible numbered path or process connecting them ... the conversion journey is CTA-present but process-absent.
Keep the lead
AI already names MedRhythms. The next edition decides if it still does.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing MedRhythms the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.